News

A recent phase 2 study revealed that the gel could act positively in microcystic lymphatic malformations, which currently have no FDA-approved treatments available.

The technology is the first non-invasive microwave treatment for cellulite to produce results on all skin types.

A recent study touts the benefits of Lycomato® oral supplement for improving fine lines and wrinkles.

The findings of this cross-sectional study indicate alopecia areata, alopecia totalis, and alopecia universalis is more common in people of color, particularly Asian Americans.

ICYMI, this week we had stories about inspiring women in dermatology for International Women's Day, a measles outbreak in Kentucky with 200,000 exposed, sarecycline's role in treating acne vulgaris, and more.

Many dermatologic conditions have demonstrated proven impacts on patients and their quality of life.

Yale School of Medicine is a testing site for a potential new congenital ichthyosis treatment.

The study suggests memantine could be considered a first-line treatment equal to behavioral therapy in the treatment process.

Study investigators evaluated the blood-brain barrier penetrance and lipophilicity of the narrow-spectrum, third-generation tetracycline-class oral antibiotic used for acne treatment.

In part 1 of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

In this episode, Mona Shahriari, MD, discusses what dermatologists and patients with atopic dermatitis can expect as we transition from winter to spring, as well as new and emerging treatments and technologies for managing atopic dermatitis that she’s looking ahead to as the year progresses.

The AbbVie company announced their partnership with the grant program to encourage women to own their own businesses.

Researchers say disease severity, site, and comorbidities may lower a patient’s quality of life as they navigate hidradenitis suppurativa.

The alert advises attendees that are not fully vaccinated to quarantine and monitor symptoms for 21 days.

In this week’s Pointers with Dr Portela, the 208SkinDoc reviews the best skin care brands for sensitive skin in 2023.

The treatment for adults and adolescents with the type 2 inflammatory skin condition has been accepted for FDA review.

A prototype for a coral-reef-friendly sunscreen is more effective at preventing sunburn in mice than existing sunscreens.

Novan’s expected PDUFA date is January 5, 2024.

Researchers conducted a pooled data analysis using previous study data to determine the cream’s efficacy in patients ages 12 and up.

JNJ-2113 met primary endpoints in the FRONTIER 1 clinical trial.

Following a systematic review and observational study meta-analysis, researchers have uncovered an association between hidradenitis suppurativa and several atopic diseases.

The commander-in-chief’s cancerous tissue was successfully removed last month.

ICYMI, this week we had stories about accepted NDAs and sBLAs for VP-102 and nivolumab, overviews of rare dermatologic diseases for National Rare Disease Day, antioxidants for vitiligo and mental health, and more.

Transplant patients are at a higher risk of nonmelanoma carcinomas due to immunosuppressive therapies.

Following 2 phase 3 trials, the European Medicines Agency Committee for Medicinal Products for Human Use gives positive opinion on the use of ruxolitinib cream as a treatment for facial-involved non-segmental vitiligo.

Convatec’s InnovaBurn device manages surgical wounds and burns, including second-degree burns.

Innovative devices are always coming to the forefront of dermatology and contribute to patient satisfaction.

Research has begun to explore natural compounds that address the oxidative stress, autoimmunity, and altered melanogenesis that drive vitiligo pathogenesis.

Following a 72-week safety and efficacy trial, researchers have determined that 1% glycopyrronium bromide cream can reduce symptoms of hyperhidrosis.

Latin America presents a patchwork of challenges and opportunities in vitiligo management according to a review published in the Journal of Dermatological Treatment.